Biotech Ideas

[gfp927z]

Blade, Just curious if you are still following MEIP? I noticed that MEIP's chart setup looks interesting for a possible upside breakout move, but I haven't kept up with the company's fundamentals. I remember last year the FDA wouldn't allow accelerated approval for MEIP's cancer drug based on the Phase 2, and would require the full Phase 3 to be completed for approval. But just curious if you might still be following the company? Yahoo Finance has their cash level at $82 mil, and revenues of $105 mil (!) and net income of $41 mil (!), which if accurate could make MEIP the bargain of the century, considering the current market cap is only $37 mil.

Thanks for any insights, and hope you are doing well :o)



---